Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
![](../../images/overlap_matrix_icon.png)
10
Number of overlapping holdings
41.7%
% of PPH's 27 holdings also in MEDX
33.3%
% of MEDX's 30 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PPH |
Weight in MEDX |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 12.5% | 16.0% | 12.5% | |
ABBVIE INC | 5.5% | 7.4% | 5.5% | |
NOVARTIS AG-ADR | 5.0% | 5.7% | 5.0% | |
ASTRAZENECA PLC-SPONS ADR | 4.9% | 5.5% | 4.9% | |
MERCK & CO. INC. | 5.7% | 4.7% | 4.7% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to MEDX
NOVO-NORDISK A/S-SPONS ADR | 9.3% | |
SANOFI-AVENTIS-ADR | 4.7% | |
ZOETIS INC | 4.6% | |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 4.5% | |
MCKESSON CORP | 4.5% | |
AMERISOURCEBERGEN CORP | 4.4% | |
TEVA PHARMACEUTICAL-SP ADR | 3.4% | |
JOHNSON & JOHNSON | 1.9% | |
GLAXOSMITHKLINE PLC-SPON ADR | 1.8% | |
VIATRIS, INC. | 1.5% |
PPH Underweight Relative to MEDX
AMGEN INC | -6.2% | |
REGENERON PHARMACEUTICALS | -4.3% | |
BIOGEN IDEC INC | -3.9% | |
ALNYLAM PHARMACEUTICALS INC | -3.8% | |
ELI LILLY & CO | -3.5% | |
IONIS PHARMACEUTICALS, INC. | -3.3% | |
CRISPR THERAPEUTICS AG | -3.2% | |
ALKERMES PLC | -3.2% | |
INTELLIA THERAPEUTICS, INC. | -2.0% | |
ABBVIE INC | -1.8% |